The innovative drug sector continued to rise. Hanson Pharmaceuticals continued to rise. Toujing Life, Yuheng Pharmaceutical, Watson Pharmaceuticals, Hainan Haiyao, and Xidian Pharmaceuticals rose and stopped, while Medici, Wanbang Pharmaceuticals, Jiankai Technology, Innox, and Mengke Pharmaceuticals continued to rise.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.